MADHAVBAUG — Vaidya Sane Ayurved Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.47bn
- IN₹1.28bn
- IN₹993.31m
- 82
- 27
- 44
- 52
Annual cashflow statement for Vaidya Sane Ayurved Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.47 | 16.1 | 47.6 | 64.3 | 28.6 |
| Depreciation | |||||
| Non-Cash Items | 9.33 | 5.69 | 0.4 | -2.97 | -5.52 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 50.1 | 11.5 | -202 | -86.7 | -98.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 77.2 | 57.8 | -131 | 0.641 | -44.1 |
| Capital Expenditures | -38.5 | -6.81 | -31.7 | -69.8 | -111 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.819 | 2.71 | -45.4 | 75 | 126 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -39.3 | -4.1 | -77.1 | 5.19 | 14.9 |
| Financing Cash Flow Items | -9.36 | -5.69 | 189 | -1.88 | -2.48 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -36.3 | -55.2 | 225 | -13.8 | 145 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.56 | -1.55 | 16.6 | -7.97 | 115 |